Amgen, AnnTaylor, CVR, Hibbett, Immunogen: U.S. Equity Preview

Shares of the following companies may have unusual moves in U.S. trading. Stock symbols are in parentheses and prices are as of 8:45 a.m. in New York.

Amgen Inc. (AMGN US) rose 1.3 percent to $55.86. The world’s largest biotechnology company said its osteoporosis drug denosumab was approved by the U.S. Food and Drug Administration for reducing fractures in prostate and breast cancer patients.

AnnTaylor Stores Corp. (ANN US) gained 9.5 percent to $26. The women’s apparel chain reported third-quarter adjusted earnings were 42 cents a share, exceeding the 34-cent average estimate by analysts. The New York-based company also raised its sales forecast for 2011 to $1.97 billion, topping analysts’ estimates of $1.95 billion on average.

Autodesk Inc. (ADSK US) declined 4.6 percent to $34.70. The maker of software used in bridge design and movie special effects forecast annual earnings excluding some items of $1.30 a share at most. That’s lower than the average analyst estimate in a Bloomberg survey of $1.31.

Blue Coat Systems Inc. (BCSI US) fell 2.2 percent to $26.50. The provider of Internet security for corporations forecast third-quarter adjusted profit of 39 cents a share at most. On average, the analysts surveyed by Bloomberg estimated earnings of 40 cents.

Bristol-Myers Squibb (BMY US) dropped 1.3 percent to $25.99. The New York-based drugmaker and Pfizer Inc. halted a trial of their experimental drug thinner after an increase in bleeding outweighed benefits for patients who recently suffered a heart attack or severe chest pain. The treatment, called apixaban, was being tested in patients with acute coronary syndrome, the two companies said yesterday in a statement. Pfizer (PFE US) slumped 1.3 percent to $16.61.

CVR Energy Inc. (CVI US) sank 6 percent to $10.80. The Sugar Land, Texas-based oil refiner announced the pricing of 18 million shares at $10.75 each in a public offering.

Dell Inc. (DELL US) rallied 3.9 percent to $14.20. The world’s third-largest supplier of personal computers reported third-quarter earnings excluding some items of 45 cents a share as declining component prices resulted in fatter margins. On average, the analysts surveyed by Bloomberg estimated profit of 32 cents a share.

Del Monte Foods Co. (DLM US) jumped 10 percent to $17. KKR & Co. is in advanced talks to buy the maker of canned fruits and Meow Mix cat food, according to the Financial Times, citing people familiar with the matter. KKR has been discussing a buyout for a price of about $18.50 a share, valuing the company at almost $3.6 billion, the newspaper said.

Foot Locker Inc. (FL US) rallied 9.5 percent to $18. The athletic shoe and apparel retailer reported third-quarter revenue of $1.28 billion, beating the average analyst estimate in a Bloomberg survey of $1.22 billion.

Gap Inc. (GPS US) slipped 2 percent to $20.50. The clothing retailer said net income fell to $303 million, or 48 cents a share, in the three months ended Oct. 30, from $307 million, or 44 cents. Analysts predicted 48 cents a share, the average of estimates tracked by Bloomberg.

Hibbett Sports Inc. (HIBB US) advanced 8.3 percent to $30.49. The sporting goods store chain reported third-quarter adjusted earnings of 44 cents a share excluding some items, beating the average analyst estimate by 6 cents.

H.J. Heinz Co. (HNZ US): The world’s biggest ketchup maker reported a second-quarter profit of 78 cents a share, beating the 76-cent average estimate from a survey of analysts. Sales were $2.61 billion, below the $2.66 billion projected by analysts.

Immunogen Inc. (IMGN US) increased 2.5 percent to $8.25. The Waltham, Massachusetts-based drugmaker announced its IMGN388 anticancer compound was “well tolerated” at certain doses.

Intuit Inc. (INTU US) fell 3.5 percent to $46.50. The provider of tax and personal-finance software forecast second- quarter profit excluding some items of 40 cents a share at most. The average analyst prediction in a Bloomberg survey was for earnings of 45 cents.

KeyCorp (KEY US) slid 3.2 percent to $7.60. Ohio’s second- largest bank said Chairman and Chief Executive Officer Henry L. Meyer will retire in May and Beth Mooney, currently vice chair of the bank and head of the lender’s community banking business, will replace him.

Mela Sciences Inc. (MELA US) surged 98 percent to $5.01. The medical device maker announced that a Food and Drug Administration advisory panel voted that skin-cancer diagnostic device MelaFind is safe and effective. Inc. (CRM US) increased 10 percent to $127.50. The world’s largest seller of online customer- management software forecast fourth-quarter sales of at least $447 million, beating the average analyst estimate of $424.6 million.

To contact the reporter on this story: Inyoung Hwang at

To contact the editor responsible for this story: Nick Baker at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.